These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29552204)

  • 1. Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma.
    Bai G; Yang M; Zheng C; Zhang L; Eli M
    Oncol Lett; 2018 Apr; 15(4):5703-5711. PubMed ID: 29552204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.
    Bai G; Chu J; Eli M; Bao Y; Wen H
    Biomed Pharmacother; 2017 Oct; 94():813-819. PubMed ID: 28802234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
    Ling ZN; Hong LL; Wu J; Ling ZQ
    Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.
    Wu HG; Zhang WJ; Ding Q; Peng G; Zou ZW; Liu T; Cao RB; Fei SJ; Li PC; Yang KY; Hu JL; Dai XF; Wu G; Li PD
    Oncol Rep; 2014 Dec; 32(6):2687-95. PubMed ID: 25310770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAQR3 plays a suppressive role in laryngeal squamous cell carcinoma.
    Wu Q; Zhuang K; Li H
    Tumour Biol; 2016 Jan; 37(1):561-5. PubMed ID: 26232324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Emerging Roles and Mechanisms of PAQR3 in Human Cancer: Pathophysiology and Therapeutic Implications.
    Guo Q; Liu XL; Zhai K; Chen C; Ke XX; Zhang J; Xu G
    Int J Gen Med; 2023; 16():4321-4328. PubMed ID: 37767187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
    Xia H; Ma L; Li J; Bai H; Wang D
    Am J Cancer Res; 2017; 7(11):2190-2198. PubMed ID: 29218243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and clinicopathologic significance of PAQR3 and VEGF-A expression in pulmonary adenocarcinoma.
    Shen XC; Zhan SH; Xu ST; Gu GJ
    Int J Clin Exp Pathol; 2020; 13(7):1676-1681. PubMed ID: 32782688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
    Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF
    Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma.
    Han T; Shu T; Dong S; Li P; Li W; Liu D; Qi R; Zhang S; Zhang L
    Oncol Lett; 2017 May; 13(5):2982-2988. PubMed ID: 28521405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma.
    Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic significance of long noncoding RNA AK001796 in esophageal squamous cell carcinoma.
    Zong MZ; Shao Q; An XS
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):181-186. PubMed ID: 30657559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
    Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
    Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.